InvestorsHub Logo
Followers 15
Posts 575
Boards Moderated 0
Alias Born 04/27/2010

Re: abrooklyn post# 2445

Friday, 09/24/2021 9:31:56 AM

Friday, September 24, 2021 9:31:56 AM

Post# of 2490
Current Report Filing (8-k)

Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________

FORM 8-K
______________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 15, 2021
______________

HEALTHTECH SOLUTIONS, INC./UT
(Exact name of registrant as specified in its charter)
______________

Utah 0-51012 84-2528660
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)

181 Dante Avenue, Tuckahoe, New York 10707
(Address of Principal Executive Office) (Zip Code)

844-926-3399
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ?

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?

1

ITEM 5.02 ELECTION OF DIRECTOR
On September 15, 2021 Edward Swanson resigned from his position as the Registrant's Chief Executive Officer, and Bradley Mathis resigned from his position as the Registrant's Chief Operating Officer. On September 16, 2021, Ryan Salomone resigned from his position as a member of the Registrant's Board of Directors.

On September 21, 2021, the Board of Directors elected Paul Mann, a member of the Board, to serve as the Chairman of the Board.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Healthtech Solutions, Inc.

Date: September 21, 2021

By:
/s/ Manuel E. Iglesias
Manuel E. Iglesias, President


2
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HLTT News